Français
514.861.1188
info@favintl.org
 
 
• Press release

Dr. Michel Chrétien, Founder and Scientific Director of the Foundation on Antivirals, has been awarded the CSBMCB Arthur Wynne Gold Medal for his life-time contribution to biochemistry, molecular and cell biology in Canada.

Montreal, April 19, 2010  -  The Foundation on Antivirals (FAV) is proud to announce that its founder and scientific director, Dr. Michel Chrétien, was presented with the Canadian Society of Biochemistry, Molecular and Cellular Biology’s prestigious Arthur Wynne Gold Medal on April 17th at an awards dinner during the Society’s 53rd Annual Meeting in Banff, Alberta.

The Arthur Wynne Gold Medal recognizes Dr. Chrétien’s life-time record of outstanding achievement in research and his major role in the development and promotion of biochemistry, molecular and cell biology in Canada, as well as his decades-long record of service to the academic community in Canada and abroad.  

Recently, Dr. Chrétien was elected Fellow of the Royal Society of London. He is the first French Canadian physician to be so honoured. 

FAV is an international foundation based in Montreal.  Its mission is to raise funds to help in the development of antivirals against HIV-AIDS, influenza, chronic fatigue syndrome, and other devastating viral threats.

For more information, please contact: 

Gil Lamy, Assistant Director – FAV
Phone:  514-861-1188, ext. 4
E-mail:glam@favintl.org

Print PDF

 
 
did you know that

Infectious diseases are a primary cause of death in the developing countries and a major impediment to their economic and social development.

  • 2.5 million people die each year from AIDS, many of them in sub-Saharan Africa
  • Over 2.5 billion people are at risk of infection with Dengue fever; and 50 million are infected each year
  • Rotavirus, a cause of common diarrhoea, kills an estimated 600,000
    children each year
  • 170 million people are chronically infected with hepatitis C – 3% of the
    world’s population
  • In West Africa alone, there are 500,000 cases of Lassa fever a year
 

The ICAV Solution

ICAV is an institutional innovation that bridges the anti-viral gap...
 

FAV Brochure

An overview of the Foundation –
Who we are
 
 
 
© Copyright - FAV International - All rights managed
Website design : Phil Communications Creative Design Studio